Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Unexpected immune complications in patients with non-Hodgkin's lymphoma receiving CD34-selected autologous peripheral stem cell transplantation

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

References

  1. Freedman AS, Ritz J, Neuberg D et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 1991; 77: 2524.

    CAS  PubMed  Google Scholar 

  2. Rohatiner A, Johnson P, Price C et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994; 12: 1177–1185.

    Article  CAS  PubMed  Google Scholar 

  3. Price CGA, Meerabux J, Murtagh S et al. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 1991; 9: 1527.

    Article  CAS  PubMed  Google Scholar 

  4. Gribben J, Neuberg D, Freedman A et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449–3457.

    CAS  PubMed  Google Scholar 

  5. Osorio S, de la Camara R, Golbano N et al. Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir. Bone Marrow Transplant 2002; 30: 963–966.

    Article  CAS  PubMed  Google Scholar 

  6. Rutella S, Rumi C, Laurenti L . Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants. Br J Haematol 2000; 108: 105–115.

    Article  CAS  PubMed  Google Scholar 

  7. Storek J, Witherspoon RP . Immunologic reconstitution after hematopoietic stem cell transplantation. In: Atkinson K (ed.). Clinical Bone Marrow and Blood Stem Cell Transplantation, Vol 1, Cambridge University Press: Boston, MA, 2000, pp 111–146.

    Google Scholar 

  8. Divine M, Boutolleau D, Delfau-Larue M et al. Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 1999; 105: 349–360.

    Article  CAS  PubMed  Google Scholar 

  9. Bomberger C, Singh-Jairam M, Rodey G . Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood 1998; 91: 2588–2600.

    CAS  PubMed  Google Scholar 

  10. Carreras E, Saiz A, Marin P et al. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 2003; 88: 306–314.

    PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by Grant FIS 95/0203 from the Fondo de Investigaciones Sanitarias from the Spanish Ministry of Health.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cordoba, R., Arranz, R. & Cannata, J. Unexpected immune complications in patients with non-Hodgkin's lymphoma receiving CD34-selected autologous peripheral stem cell transplantation. Bone Marrow Transplant 35, 1217–1218 (2005). https://doi.org/10.1038/sj.bmt.1704977

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704977

Search

Quick links